Back to News
Market Impact: 0.08
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
Source: PR Newswire
Healthcare & BiotechArtificial Intelligence
Compugen, a clinical-stage cancer immunotherapy company using AI-powered computational target discovery, announced that management will participate in a fireside chat and conduct one-on-one meetings. The announcement contains no clinical data, financial results, guidance, partnership, or other material operating update.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
CGEN0.10
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- AI Doubts Spread Cracks in Equities, Credit Markets: Evening Briefing Americas
- Kinder Morgan, Energy Transfer and Williams could benefit from cheap natural gas
- CrowdStrike CEO's alarming prediction — plus, the sell-off spreads beyond tech
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More
- AI Software for Buy-Side Teams: Build the Research Stack